Crossmark

ASO Author Reflections: Commercialization of Adaptive Cell Therapy for Metastatic Melanoma

Published Online: 2022-09-26

Published Print: 2023-01

Authors

Kooragayala, Keshav

Lou, Johanna https://orcid.org/0000-0003-2949-3382
Hong, Young Ki
License Information

Text and Data Mining valid from 2022-09-26

Version of Record valid from 2022-09-26
More Information

Article History

Received: 7 September 2022

Accepted: 7 September 2022

First Online: 26 September 2022

Disclosures

: Y.K.H. is a consultant for Castle Biosciences and IOVANCE Biotherapeutics.

Document is current